within Pharmacolibrary.Drugs.ATC.B;

model B01AB04
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 2.7999999999999996e-05,
    adminDuration  = 600,
    adminMass      = 5000 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 7.000000000000001e-05,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>B01AB04</td></tr><td>route:</td><td>subcutaneous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Dalteparin is a low molecular weight heparin (LMWH) used as an anticoagulant for the prevention and treatment of deep vein thrombosis, pulmonary embolism, and for prophylaxis in patients undergoing surgery or at increased risk of thromboembolic events. It is approved and widely used today for these indications.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers (both male and female) after single subcutaneous injection.</p><h4>References</h4><ol><li><p>Howard, PA (1997). Dalteparin: a low-molecular-weight heparin. <i>The Annals of pharmacotherapy</i> 31(2) 192–203. DOI:<a href=&quot;https://doi.org/10.1177/106002809703100212&quot;>10.1177/106002809703100212</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9034422/&quot;>https://pubmed.ncbi.nlm.nih.gov/9034422</a></p></li><li><p>Reverter, JC (2002). Fondaparinux sodium. <i>Drugs of today (Barcelona, Spain : 1998)</i> 38(3) 185–194. DOI:<a href=&quot;https://doi.org/10.1358/dot.2002.38.3.820126&quot;>10.1358/dot.2002.38.3.820126</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/12532174/&quot;>https://pubmed.ncbi.nlm.nih.gov/12532174</a></p></li><li><p>Rommers, MK, et al., &amp; van den Bemt, PM (2006). Anti-Xa activity after subcutaneous administration of dalteparin in ICU patients with and without subcutaneous oedema: a pilot study. <i>Critical care (London, England)</i> 10(3) R93–None. DOI:<a href=&quot;https://doi.org/10.1186/cc4952&quot;>10.1186/cc4952</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/16790078/&quot;>https://pubmed.ncbi.nlm.nih.gov/16790078</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end B01AB04;
